Advances in Cardiovascular Pharmacotherapy. IV. Sodium-Glucose Cotransporter Type 2 Inhibitors, Part 2: Mechanisms for Myocardial Protection, Adverse Effects, and Perioperative Implications.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of cardiothoracic and vascular anesthesia"
DOI: 10.1053/j.jvca.2025.06.015
Abstract: This second part of a two-part review on the cardiovascular pharmacology of sodium-glucose cotransporter type 2 inhibitors (SGLT2i) describes the mechanisms that have been proposed to explain how these drugs improve outcomes in heart failure… read more here.
Keywords: type inhibitors; glucose cotransporter; adverse effects; cotransporter type ... See more keywords
Sodium–glucose cotransporter type 2 inhibitors: managing the small but critical risk of diabetic ketoacidosis
Sign Up to like & getrecommendations! Published in 2020 at "Medical Journal of Australia"
DOI: 10.5694/mja2.50899
Abstract: First, clinicians should be aware that this condition occurs not only in the perioperative context but also in systemically unwell patients with medical problems. Apart from the periprocedural insult, four categories of precipitating factors are… read more here.
Keywords: sodium glucose; cotransporter type; type inhibitors; inhibitors managing ... See more keywords